We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
These are the countries and jurisdictions from whom the TGA will accept reports for use in the prescription medicines COR report-based process. This initial list has been determined by the Secretary for the purposes of subregulation 16DA(3) of the Therapeutic Goods Regulations 1990.
| Country or Jurisdiction | Regulatory Authority |
|---|---|
| Countries | |
| Canada | Health Canada |
| Japan | Pharmaceuticals and Medical Devices Agency (PMDA) |
| Singapore | Health Science Authority Singapore (HSA) |
| Switzerland | SwissMedic |
| United Kingdom | Medicines and Healthcare products Regulatory Agency (MHRA) |
| United States | Food and Drug Administration (FDA) |
| Jurisdictions | |
| European Union | European Medicines Agency (EMA) - centralised and decentralised processes |
The application of the Stage 1 criteria to the above list was significantly informed by our existing involvement in several international initiatives aimed at reducing the duplication of work across agencies and convergence of medicines regulation through information-sharing and confidence-building.